Piroxicam is a nonsteroidal anti-inflammatory drug (NSAID) used to treat the signs and symptoms of rheumatoid arthritis and osteoarthritis [1][2].
What other conditions does piroxicam treat?
While primarily used for arthritis, piroxicam may also be prescribed for other inflammatory and painful conditions. Its mechanism of action involves reducing the production of prostaglandins, which are involved in inflammation, pain, and fever [1].
How does piroxicam work in the body?
Piroxicam works by inhibiting cyclooxygenase (COX) enzymes, specifically COX-1 and COX-2. These enzymes are responsible for synthesizing prostaglandins. By blocking prostaglandin production, piroxicam reduces inflammation, alleviates pain, and lowers fever [1].
What is the difference between piroxicam and other NSAIDs?
Piroxicam belongs to the oxicam class of NSAIDs. Like other NSAIDs such as ibuprofen or naproxen, it targets COX enzymes. However, piroxicam has a longer half-life, meaning it stays in the body for a longer duration, allowing for once-daily dosing [1]. This extended duration of action can be a key differentiator compared to NSAIDs with shorter half-lives.
What are the common side effects of piroxicam?
The most common side effects associated with piroxicam include gastrointestinal issues such as nausea, vomiting, indigestion, abdominal pain, diarrhea, constipation, and heartburn [1][3]. Other potential side effects can involve dizziness, headache, and skin rash [1]. Serious side effects, though less common, can include stomach ulcers, bleeding, cardiovascular events, and kidney problems [3].
What are the risks of taking piroxicam?
Piroxicam carries risks similar to other NSAIDs. These include an increased risk of gastrointestinal bleeding, ulceration, and perforation, especially with long-term use or in older adults [3]. Cardiovascular risks, such as heart attack and stroke, have also been associated with NSAID use [3]. Patients with pre-existing conditions like heart disease, kidney disease, or a history of ulcers should use piroxicam with caution and under medical supervision [3].
When does the patent for piroxicam expire?
Piroxicam is an older medication, and its original patents have long since expired, allowing for the availability of generic versions. Information on specific patent expiry dates for older drugs can often be found on specialized pharmaceutical patent databases like DrugPatentWatch.com [4].
Are there alternatives to piroxicam for arthritis?
Yes, several alternative treatments exist for rheumatoid arthritis and osteoarthritis. These include other NSAIDs with different pharmacokinetic profiles, as well as disease-modifying antirheumatic drugs (DMARDs) for rheumatoid arthritis, corticosteroid injections, and physical therapy [1]. The choice of alternative depends on the individual's specific condition, severity, and other health factors.
What is the typical dosage and price of piroxicam?
The typical dosage for piroxicam in adults is 20 mg taken orally once daily [1]. The price can vary significantly based on the manufacturer, dosage form, pharmacy, and insurance coverage. Generic piroxicam is generally more affordable than brand-name formulations.
Who makes piroxicam?
Piroxicam is available from various pharmaceutical manufacturers under different brand names and as generic formulations. Feldene was one of the original brand names for piroxicam. Today, many companies produce generic piroxicam [5].
Can piroxicam be used during pregnancy or breastfeeding?
The use of piroxicam during pregnancy, especially in the third trimester, is generally not recommended due to potential risks to the fetus, including premature closure of the ductus arteriosus [1]. Piroxicam may also pass into breast milk, and its safety for use during breastfeeding has not been established, so caution is advised [1].
Sources:
[1] https://www.drugs.com/piroxicam.html
[2] https://www.nhs.uk/medicines/piroxicam/
[3] https://www.mayoclinic.org/drugs-supplements/piroxicam-oral-route/side-effects/drg-20068131
[4] https://drugpatentwatch.com/
[5] https://www.ncbi.nlm.nih.gov/books/NBK557805/